{"nct_id":"NCT03848845","title":"Study Evaluating Safety, Tolerability and Clinical Activity of GSK2857916 in Combination With Pembrolizumab in Subjects With Relapsed/Refractory Multiple Myeloma (RRMM)","status":"COMPLETED","status_verified_date":"2024-03","start_date":"2019-03-14","start_date_type":"ACTUAL","primary_completion_date":"2021-10-18","primary_completion_date_type":"ACTUAL","completion_date":"2023-06-14","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["GSK"]}